A Retrospective Cohort Study of Infusion Reactions Due to Vectibix.

Trial Profile

A Retrospective Cohort Study of Infusion Reactions Due to Vectibix.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Nov 2013

At a glance

  • Drugs Panitumumab (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 08 Jun 2012 Planned End Date changed from 1 Mar 2011 to 1 Mar 2013 as reported by ClinicalTrials.gov.
    • 30 Dec 2010 Additional lead trial investigator (Peacock N) added as reported by ClinicalTrials.gov.
    • 12 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top